Abstract
A novel coronavirus termed nCoV-2019 that caused an epidemic of acute respiratory syndrome in humans was first detected in Wuhan, China, in December 2019. nCoV-2019 resulted in thousands of cases of lethal disease all around the world. Unfortunately, there is no specific treatment yet, so a better understanding of the pathobiology of the disease can be helpful. The renin-angiotensin system and its products have several important physiological actions. On the other hand, this system is involved in the pathogenesis of various diseases. In this context, this review article will briefly discuss insights for understanding the role of the angiotensin-converting enzyme 2 (ACE2) receptor as a potentially attractive target for the nCoV-2019-induced acute respiratory syndrome.
Keywords: COVID-19, renin-angiotensin system, ACE2, angiotensin, SARS-like coronavirus, acute respiratory syndrome.
Current Drug Discovery Technologies
Title:ACE2 as a Potential Target for Management of Novel Coronavirus (nCoV- 2019)
Volume: 18 Issue: 6
Author(s): Elham Foroozanfar, Mohamad Forouzanfar, Tahereh Farkhondeh, Saeed Samarghandian and Fatemeh Forouzanfar*
Affiliation:
- Department of Neuroscience, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad,,Iran
Keywords: COVID-19, renin-angiotensin system, ACE2, angiotensin, SARS-like coronavirus, acute respiratory syndrome.
Abstract: A novel coronavirus termed nCoV-2019 that caused an epidemic of acute respiratory syndrome in humans was first detected in Wuhan, China, in December 2019. nCoV-2019 resulted in thousands of cases of lethal disease all around the world. Unfortunately, there is no specific treatment yet, so a better understanding of the pathobiology of the disease can be helpful. The renin-angiotensin system and its products have several important physiological actions. On the other hand, this system is involved in the pathogenesis of various diseases. In this context, this review article will briefly discuss insights for understanding the role of the angiotensin-converting enzyme 2 (ACE2) receptor as a potentially attractive target for the nCoV-2019-induced acute respiratory syndrome.
Export Options
About this article
Cite this article as:
Foroozanfar Elham , Forouzanfar Mohamad , Farkhondeh Tahereh , Samarghandian Saeed and Forouzanfar Fatemeh *, ACE2 as a Potential Target for Management of Novel Coronavirus (nCoV- 2019), Current Drug Discovery Technologies 2021; 18 (6) : e130921189567 . https://dx.doi.org/10.2174/1570163817999201228215911
DOI https://dx.doi.org/10.2174/1570163817999201228215911 |
Print ISSN 1570-1638 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6220 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Association of SARS-CoV-2 Infection and Triple Negative Breast Cancer
(TNBC) A Computational Illustrative Study
Letters in Drug Design & Discovery Molecular Hybridization as a Tool for Designing Multitarget Drug Candidates for Complex Diseases
Current Topics in Medicinal Chemistry The Immucillins: Design, Synthesis and Application of Transition- State Analogues
Current Medicinal Chemistry Medicinal Chemistry Approaches to the Inhibition of Dipeptidyl Peptidase IV
Current Topics in Medicinal Chemistry Editorial (Thematic Issue: Allosteric Modulators of G Protein-Coupled Receptors)
Current Topics in Medicinal Chemistry Discovery of Inhibitors of Protein-Protein Interactions from Combinatorial Libraries
Current Topics in Medicinal Chemistry MicroRNA and Exosome in Retinal-related Diseases: Their Roles in the Pathogenesis and Diagnosis
Combinatorial Chemistry & High Throughput Screening Molecular Design and QSARs/QSPRs with Molecular Descriptors Family
Current Computer-Aided Drug Design Experimental and Computational Approaches for SARS-CoV-2 Theranostics
Current Pharmaceutical Design Structure Based Drug Design Approach to Identify Potential SARS-CoV-2 Polymerase Inhibitors
Coronaviruses Metabolic and Functional Brain Mapping, Connectivity and Plasticity Applied to the Surgery of Cerebral Tumors
Current Medical Imaging Prediction of Thrombin and Factor Xa Inhibitory Activity with Associative Neural Networks
Current Computer-Aided Drug Design Ligand-Based Computer-Aided Discovery of Tyrosinase Inhibitors. Applications of the TOMOCOMD-CARDD Method to the Elucidation of New Compounds
Current Pharmaceutical Design Synthesis and Biological Evaluation of 1, 3-Dihydroxyxanthone Mannich Base Derivatives as Potential Antitumor Agents
Letters in Drug Design & Discovery Journey Describing the Discoveries of Anti-HIV Triterpene Acid Families Targeting HIV-Entry/Fusion, Protease Functioning and Maturation Stages
Current Topics in Medicinal Chemistry Recent Progress in the Discovery of Novel Glucocorticoid Receptor Modulators
Current Topics in Medicinal Chemistry An Agathokakological Tale of Δ<sup>9</sup>-THC: Exploration of Possible Biological Targets
Current Drug Targets New Development of Novel Berberine Derivatives against Bacteria
Mini-Reviews in Medicinal Chemistry 1+1 > 2: Integration of the Host-directed Traditional Chinese Medicine and the Virus-targeted Modern Medicine in Control of COVID-19
Clinical Cancer Drugs Inspiratory and Expiratory Chest High-resolution CT: Small-airway Disease Evaluation in Patients with COVID-19
Current Medical Imaging